These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11173980)

  • 1. Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials.
    Walter H; Ramskogler K; Semler B; Lesch OM; Platz W
    J Biomed Sci; 2001; 8(1):83-8. PubMed ID: 11173980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats.
    Liu X; Weiss F
    J Pharmacol Exp Ther; 2002 Mar; 300(3):882-9. PubMed ID: 11861794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact discrimination reversal learning but slowed responding to reward-predictive cues after dopamine D1 and D2 receptor blockade in the nucleus accumbens of rats.
    Calaminus C; Hauber W
    Psychopharmacology (Berl); 2007 Apr; 191(3):551-66. PubMed ID: 17021925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
    Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
    Peacock L; Hansen L; Mørkeberg F; Gerlach J
    Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1/D2 Receptor Activity in the Nucleus Accumbens Core But Not in the Nucleus Accumbens Shell and Orbitofrontal Cortex Modulates Risk-Based Decision Making.
    Mai B; Sommer S; Hauber W
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv043. PubMed ID: 25908669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats.
    Sari Y; Bell RL; Zhou FC
    Alcohol Clin Exp Res; 2006 Jan; 30(1):46-56. PubMed ID: 16433731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.
    Pardo M; López-Cruz L; San Miguel N; Salamone JD; Correa M
    Psychopharmacology (Berl); 2015 Jul; 232(13):2377-91. PubMed ID: 25647696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 or D2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8.
    Bednar I; Carrer H; Qureshi GA; Södersten P
    Am J Physiol; 1995 Oct; 269(4 Pt 2):R896-903. PubMed ID: 7485609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin A induced antinociception in the ventral tegmental area involves D1 and D2 receptors in the nucleus accumbens.
    Yazdi-Ravandi S; Razavi Y; Haghparast A; Goudarzvand M; Haghparast A
    Pharmacol Biochem Behav; 2014 Nov; 126():1-6. PubMed ID: 25179164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.
    Bender S; Scherbaum N; Soyka M; Rüther E; Mann K; Gastpar M
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):653-60. PubMed ID: 17076934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus accumbens dopaminergic neurotransmission switches its modulatory action in chronification of inflammatory hyperalgesia.
    Dias EV; Sartori CR; Marião PR; Vieira AS; Camargo LC; Athie MC; Pagliusi MO; Tambeli CH; Parada CA
    Eur J Neurosci; 2015 Oct; 42(7):2380-9. PubMed ID: 26173870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 and D2 specific dopamine antagonist modulate the caudate nucleus neuronal responses to chronic methylphenidate exposure.
    Venkataraman S; Claussen C; Dafny N
    J Neural Transm (Vienna); 2017 Feb; 124(2):159-170. PubMed ID: 27853928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of nucleus accumbens dopamine D1 receptor blockade on consumption during the first two days of operant self-administration of sweetened ethanol in adult Long-Evans rats.
    Doherty JM; Gonzales RA
    Alcohol; 2015 Sep; 49(6):543-51. PubMed ID: 26142563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.